The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.
Role of TET enzymes in DNA methylation, development, and cancer
Open accessAbstract
The pattern of DNA methylation at cytosine bases in the genome is tightly linked to gene expression, and DNA methylation abnormalities are often observed in diseases. The ten eleven translocation (TET) enzymes oxidize 5-methylcytosines (5mCs) and promote locus-specific reversal of DNA methylation. TET genes, and especially TET2 , are frequently mutated in various cancers, but how the TET proteins contribute to prevent the onset and maintenance of these malignancies is largely unknown. Here, we highlight recent advances in understanding the physiological function of the TET proteins and their role in regulating DNA methylation and transcription. In addition, we discuss some of the key outstanding questions in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Generally, 2OGO catalyze specific hydroxylation of substrates, which, in turn, leads to demethylations via other catalytic cycles or downstream pathway involving thymine-DNA-glycosylase, which catalyzed base excision with DNA base excision repair [101,120].”
From Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“TET2 is frequently mutated or lost somatically in both myeloid and lymphoid malignancies63,64.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“Thus, it was remarkable when ten eleven translocation protein 1 (TET1) was discovered and shown to be able to modify methylcytosine and potentially erase DNAmethylation (Tahiliani et al. 2009).”
BackgroundGenomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Second, TET2 mutations are frequently observed in aged healthy individuals with clonal hematopoiesis and increase the propensity to develop hematopoieticmalignancies (Busque et al. 2012; Genovese et al. 2014; Jaiswal et al. 2014; Xie et al. 2014).”
BackgroundClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · cited 1×
“Second, TET2 mutations are frequently observed in aged healthy individuals with clonal hematopoiesis and increase the propensity to develop hematopoieticmalignancies (Busque et al. 2012; Genovese et al. 2014; Jaiswal et al. 2014; Xie et al. 2014).”
BackgroundTet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451 · cited 3×
“6-fold) substrates compared with the initial oxidation reaction of 5mC (Ito et al. 2011; Hu et al. 2015).”
BackgroundXu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776 · cited 4×
“Subsequent to the discovery of oxidized 5mC bases, it was demonstrated that TDG has no effect on 5hmC but shows robust recruitment and in vitro catalytic activity toward 5fC and 5caC (He et al. 2011; Maiti and Drohat 2011; Spruijt et al. 2013).”
BackgroundInfluentialFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain
Kriaucionis, S., & Heintz, N. (2009) · Science · doi:10.1126/science.1169786 · Cited by 2,700 · cited 1×
“By comparison, the products of further TET-mediated oxidation, 5fC and 5caC, are observed at ∼10-fold to 100-fold lower levels than 5hmC and often close to or under the detection limit (Kriaucionis and Heintz 2009; Globisch et al. 2010; Szwagierczak et al. 2010; He et al. 2011; Ito et al. 2011; Pfaffeneder et al. 2011…”
Background
Flagged first, then by citations
1 of the 162 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,001
Xu, Y. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0297 · Cited by 6
Gerdol, M., Vecchia, C. L., Strazzullo, M., Luca, P. D., Gorbi, S., Regoli, F., Pallavicini, A., & D’Aniello, E. (2021) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2021.698561 · Cited by 6
“The recent discovery of TETs can be considered as one of the hallmarks in epigenetics, due to the key role these genes play in oncogenesis, but also in development (Rasmussen and Helin, 2016).”
BackgroundLejart, A., Zentout, S., Chapuis, C., D’Augustin, O., Smith, R., Salbert, G., & Huet, S. (2022) · Chromosoma · doi:10.1007/s00412-022-00769-0 · Cited by 7
“By controlling the balance of 5-mC/5hmC levels within the genome, the TET enzymes are key regulators of transcriptional processes associated with cell differentiation, tumorigenesis, and neurodegeneration (Rasmussen and Helin 2016; Jin et al. 2016).”
BackgroundMissing Causality and Heritability of Autoimmune Hepatitis
Czaja, A. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07728-w · Cited by 6
Reactive Oxygen Species and Their Epigenetic Consequences in Heart Diseases
Bhargava, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_6 · Cited by 6
A Fresh Take on the “TCA” Cycle: TETs, Citrate, and Asthma
Huang, S. K. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0101ed · Cited by 6
“The importance of TET enzymes is now recognized in many diseases (11); indeed, they were initially discovered and named because the gene was commonly found translocated in acute myelogenous leukemia.”
BackgroundFleming, A., Knatko, E. V., Li, X., Zoch, A., Heckhausen, Z., Stransky, S., Brenes, A. J., Sidoli, S., Hájková, P., O’Carroll, D., et al. (2024) · Genes & Development · doi:10.1101/gad.352176.124 · Cited by 5
Self-citationGawroński, M., Starczak, M., Wasilow, A., Dziaman, T., Oliński, R., & Gackowski, D. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00634-1 · Cited by 5
“Genetic studies strongly suggest that TET proteins are functionally nonredundant, most likely due to varying expression levels and recruitment mechanisms [62].”
5-Methylpyrimidines and Their Modifications in DNA
Parker, M. J., Lee, Y., Weigele, P., & Saleh, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14838-3 · Cited by 5
Hong, S. H., Yu, X., Zhu, Y., & Chen, Y. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111093 · Cited by 5
Adsorption of rare bases on transition metal doped γ-graphyne nanosheets: a DFT study
Zeng, X., Zhang, R., Li, R., Li, R., Cui, H., Zhao, C., Zhang, S., & Jin, L. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d4cp03128h · Cited by 5
Fritsch, H. M., Giovanetti, M., Clemente, L. G., Fernandes, G. D. R., Fonseca, V., de Lima, M. M., Falcão, M., de Jesus, N., de Cerqueira, E. M., da Cunha, R. V., et al. (2024) · Genes · doi:10.3390/genes15111365 · Cited by 4
“KDM3B and TET2 remove methyl groups, with roles in active DNA demethylation [65].”
Jyotirmaya, S. S., Rath, S., & Dandapat, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156380 · Cited by 5
Treating Hematological Malignancies With OR ‐2100, an Orally Bioavailable Prodrug of Decitabine
Watanabe, T., Kidoguchi, K., & Kimura, S. H. (2025) · Cancer Science · doi:10.1111/cas.16452 · Cited by 5
Epigenetics of Transgenerational Inheritance of Disease
Blake, G. E. T., Rakoczy, J., & Watson, E. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00026-1 · Cited by 5
Kojima, N., Suda, T., Fujii, S., Hirano, K., Namihira, M., & Kurita, R. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112472 · Cited by 5
Palei, S., Weisner, J., Vogt, M., Gontla, R., Buchmuller, B. C., Ehrt, C., Grabe, T., Kleinboelting, S., Müller, M. P., Clever, G. H., et al. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00186a · Cited by 5
Ten-Eleven-Translocation Genes in Cancer
Wang, Y., Wang, X., & Lü, J. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-45654-1_11 · Cited by 5
The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review
Da, W., Song, Z., Liu, X., Wang, Y., Wang, S., & Ma, J. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03478-5 · Cited by 5
“Targeting TET2 holds great promise in effectively inhibiting tumor growth, as the methylation of oncogenes or tumor suppressors is known to contribute to tumor development and maintenance [65, 66].”
Cheng, P., Xia, R., & Wang, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-21 · Cited by 7
Hojjatipour, T., Ajeli, M., Maali, A., & Azad, M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104498 · Cited by 5
Gorse, M., Bianchi, C., & Proudhon, C. (2024) · médecine/sciences · doi:10.1051/medsci/2024180 · Cited by 5
Liu, Y., Du, D., Gu, X., He, Q., & Xiong, B. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70282 · Cited by 5
Adventures in Defining Roles of Oxygenases in the Regulation of Protein Biosynthesis
Walport, L. J., & Schofield, C. J. (2018) · The Chemical Record · doi:10.1002/tcr.201800056 · Cited by 5
Quantification of global DNA methylation level using 5-methylcytosine dioxygenase
Taka, N., & Yoshida, W. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02745-y · Cited by 5
Martínez-Valiente, C., García-Ruiz, C., Rosón, B., Liquori, A., González-Romero, E., Fernández‐González, R., Gómez‐Redondo, I., Cervera, J., Gutiérrez‐Adán, A., & Sanjuán-Pla, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136963 · Cited by 5
“At the cellular level, TET2 is involved in the regulation of HSC self-renewal and myeloid lineage commitment [27].”
BackgroundSmoking Methylation Marks for Prediction of Urothelial Cancer Risk
Yu, C., Jordahl, K. M., Bassett, J. K., Joo, J. E., Wong, E. M., Brinkman, M. T., Schmidt, D., Bolton, D., Makalic, E., Brasky, T. M., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0313 · Cited by 5
“For example, TET proteins may stimulate and regulate DNA methylation at genes that were included (48), but this requires further investigation using functional studies.”
Hayashi, T., Eto, K., & Kadoya, Y. (2022) · Differentiation · doi:10.1016/j.diff.2022.05.001 · Cited by 4
Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms
Li, J., Hong, T., Wei, Y., Guo, L. M., Lee, M., Yang, H., Class, C. A., Yang, Y., Wang, X., He, H., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01297-5 · Cited by 5
“TET proteins are well known as tumor suppressors [11, 12].”
BackgroundDing, M., Wang, Q., Zhu, W., Chang, J. H., Liao, H., & Xiao, G. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02275-0 · Cited by 5
“DNA methylation is a major epigenetic change associated with cancer that may lead to transcriptional silencing of tumor suppressor genes [23].”
BackgroundZheng, X., Wu, W., Zhou, Q., Lian, Y., Xiang, Y., & Zhao, X. (2023) · Clinical Science · doi:10.1042/cs20220644 · Cited by 5
MiR-183-5p promotes migration and invasion of prostate cancer by targeting TET1
Feng, Y., Wang, K., Qin, M., Zhuang, Q., & Chen, Z. (2023) · BMC Urology · doi:10.1186/s12894-023-01286-7 · Cited by 5
“It is a DNA demethylase that hydroxylates 5-methylcytosine (5mC) to 5-hydroxymetylcytosine (5hmC), thereby facilitates active DNA demethylation [8, 24].”
BackgroundTranscription regulation by DNA methylation under stressful conditions in human cancer
Cao, S., Zhou, Y., Wu, Y., Song, T., Alsaihati, B. A., & Xu, Y. (2017) · Quantitative Biology · doi:10.1007/s40484-017-0129-y · Cited by 5
“The DNA methylation enzyme genes used in the study are the DNA methyltransferase: DNMT1, DNMT3A, DNMT3B [26]; and the DNA de-methylation enzymes genes are: TET1-3 and TGD [27,28].”
MethodYu, W., Fu, J., Wu, W., & Wu, J. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3539 · Cited by 6
Sight restored by turning back the epigenetic clock
Huberman, A. D. (2020) · Nature · doi:10.1038/d41586-020-03119-1 · Cited by 5
Ma, R., Tang, N., Feng, L., Wang, X., Zhang, J., Ren, X., Du, Y., & Ouyang, F. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113051 · Cited by 5
Micronutrient regulation of the DNA methylome
Leesang, T. E., Lyon, P. D., Pinzone, J., & Cimmino, L. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1409355 · Cited by 5
“TET activity is primarily associated with gene activation, given the enrichment of 5hmC within enhancers and gene bodies of actively expressed genes (Ficz et al., 2011; Rasmussen and Helin, 2016).”
Hernández‐Núñez, I., Urman, A., Zhang, X., Jacobs, W., Hoffmann, C. M., Rebba, S., Harding, E. G., Li, Q., Mao, F., Cani, A. K., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003332 · Cited by 4
“5hmC is further oxidized by the Tet enzymes to produce 5-formilcytosine (5-fC) and 5-carboxylcytosine (5-caC) [48] which are then converted back to cytosine by Thymine DNA-Glycosylase (TDG) and the base-excision repair (BER) pathway (Fig 1A) [43,49–53].”
Depression: epigenetics and epitranscriptomic modifications
Banerjee, S., Shrilaxmi, M. S., Banerjee, S., Prajwal, B. G., Smith, C., D’Mello, S. R., & Dastidar, S. G. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2602171 · Cited by 4
Metabolic Remodeling Impacts the Epigenetic Landscape of Dental Mesenchymal Stem Cells
Luo, H., Zhou, Y., & Liu, W. (2022) · Stem Cells International · doi:10.1155/2022/3490433 · Cited by 5
TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation
Xiang, C., Gao, L., Tao, Q., Chen, Z., Zhao, S., & Liu, W. (2024) · Hematological Oncology · doi:10.1002/hon.3295 · Cited by 4
“21 Numerous studies have reported mutations of TET2 participation in various cancer progression.”
Tolić, A., Rajić, J., Djordjević, M., Djordjevic, M., Dinić, S., Grdović, N., Јovanović, J. A., Mihailović, M., Poznanović, G., Jurkowski, T. P., et al. (2019) · Archives of Biological Sciences · doi:10.2298/abs190404027t · Cited by 4
“The activity of TETs can be modulated by metabolites, cofactors and several post-translational modifications [35].”
BackgroundYuan, Z., Zhang, D., Yu, F., Ma, Y., Liu, Y., Li, X., & Wang, H. (2021) · Chemical Science · doi:10.1039/d0sc01742f · Cited by 4
Saad, L., Kalsbeek, A., Zwiller, J., & Anglard, P. (2021) · Genes · doi:10.3390/genes12081195 · Cited by 5
“The regulation of DNA methylation factors by both agents raises questions regarding their common and tissue-specific target-methylated DNA sequences [88,101,102] and their role in the establishment and development of drug addiction.”
BackgroundKong, R., Zhang, H., Jia, Y. H., Man, Q., & Liu, S. (2022) · Epigenomics · doi:10.2217/epi-2022-0395 · Cited by 4
Transcriptional Factors Mediated Reprogramming to Pluripotency
Fatima, N., Rahman, M. S. U., Qasim, M., Ashfaq, U. A., Ahmed, U., & Masoud, M. S. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230417084518 · Cited by 5
Bhatkar, D., Ananda, N., Lokhande, K. B., Khunteta, K., Jain, P., Hebale, A., Sarode, S. C., & Sharma, N. K. (2023) · Journal of Cancer Prevention · doi:10.15430/jcp.2023.28.3.115 · Cited by 4
“Our findings on SABFI-derived organic acids as potential inhibitors of TET2 agree with current views on the metabolic-epigenomic axis in cancer cells [13-18].”
BackgroundInfluentialXu, L. Z., & Cai, M. (2023) · Life · doi:10.3390/life13122253 · Cited by 4
“DNMTs and TETs play pivotal roles in governing dynamic changes in DNA methylation [33].”
BackgroundInfluentialArai, K., Qi, H., & Inoue‐Murayama, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294994 · Cited by 4
Tet controls axon guidance in early brain development through glutamatergic signaling
Tran, H., Le, L., Singh, B. N., Kramer, J., & Steward, R. (2024) · iScience · doi:10.1016/j.isci.2024.109634 · Cited by 4
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer
Picard, L. C., Rich, F. J., Kenwright, D., & Stevens, A. J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189123 · Cited by 4
Barciszewska, A., Belter, A., Barciszewski, J. F., Gawrońska, I., Giel-Pietraszuk, M., & Naskręt-Barciszewska, M. Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179460 · Cited by 4
“It can take place through oxidative demethylation catalyzed with Ten-Eleven Translocation (TET) enzymes, which are oxo-reductases, or through spontaneous oxidation and methyl group removal as a result of the action of reactive oxygen species (ROS) [21].”
BackgroundRen, X., Yang, Y., Wang, M., Yuan, Q., Suo, N., & Xie, X. (2024) · Molecules · doi:10.3390/molecules29245939 · Cited by 4
“Apart from antioxidant activity, Vc regulates the activity of TET (ten-eleven translocation) enzymes, which mediate the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and play a critical role in DNA demethylation [21].”
Cai, X., Guo, W., Wu, F., Xu, W., Ding, T., Diao, Y., Wang, L., Qian, Z., & Song, G. (2025) · BMC Cancer · doi:10.1186/s12885-025-14028-9 · Cited by 4
“Previous research suggests that DNMT3L interacts with DNMT3A/B to facilitate methylation [27], whereas proteins of the TET family exert an opposing effect [28, 29].”
DNA Methylation in Eukaryotes: Regulation and Function
Niller, H. H., Demcsák, A., & Minárovits, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-20796-4_24-1 · Cited by 4
Mutations in DNA Methyltransferases and Demethylases
Sun, X., Chen, Z., & Chen, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65054-7 · Cited by 4
Heiblig, M., Khalife‐Hachem, S., Willekens, C., Micol, J., Paci, A., Penard‐Lacronique, V., & de Botton, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1831909 · Cited by 4
Epigenetic Clock: A Novel Tool for Nutrition Studies of Healthy Ageing
He, L. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1773-0 · Cited by 4
“…removal of methyl groups (i.e., DNA demethylation) can happen either passively by failing to maintain the methylation patterns after replication or actively through oxidizing methylated cytosine into 5-hydroxymethylcytosine (5-hmC), a process mediated by ten-eleven translocation (TET) enzymes (4).”
Murray, D. D., Grund, B., MacPherson, C. R., Ekenberg, C., Zucco, A. G., Reekie, J., Domínguez, L., Leung, P., Fusco, D. N., Gras, J., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003427 · Cited by 4
Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy
de Nys, R., van Eyk, C. L., Ritchie, T., Møller, R. S., Scheffer, I. E., Marini, C., Bhattacharjee, R., Kumar, R., & Gécz, J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02783-5 · Cited by 4
Moshari, S., Razi, M., Nasr‐Esfahani, M. H., Tavalaee, M., & Hajian, M. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01651-3 · Cited by 4
“Several articles have shown that ten-eleven-translocation (TET) proteins are actively involved in oxidizing 5mC to 5hmC in the testicular tissue and at early stages after oocyte fertilization which is known as "active DNA demethylation (ADD)" [18].”
DNA demethylation pattern of in-vitro fertilized and cloned porcine pronuclear stage embryos
Nie, X., Liu, Q., Wang, R., Sheng, W., Li, X., Zhang, M., Jin, Y., Zhao, L., Hou, D., Yang, N., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.07.025 · Cited by 4
Technologies and applications for the assessment of 5-hydroxymethylcytosine
Jurkowski, T. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819414-0.00013-6 · Cited by 4
Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models
Ono, R., Masuya, M., Inoue, N., Shinmei, M., Ishii, S., Maegawa, Y., Maharjan, B. D., Katayama, N., & Nosaka, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248425 · Cited by 4
“Tet1 has a catalytic dioxygenase domain consisting of a cysteine (Cys)-rich region and a double-stranded β-helix (DSBH) at the C-terminal part [8].”
BackgroundMulholland, C. B., Nishiyama, A., Ryan, J., Nakamura, R., Yiğit, M., Glück, I. M., Trummer, C., Qin, W., Bartoschek, M. D., Traube, F. R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/321604 · Cited by 4
Avendaño, C., & Menéndez, J. C. (2023) · Medicinal Chemistry of Anticancer Drugs · doi:10.1016/b978-0-12-818549-0.00019-4 · Cited by 4
Liu, X., Yang, S., Jiang, J., Dong, S., & Zhang, Y. (2025) · Oral Science and Homeostatic Medicine · doi:10.26599/oshm.2025.9610013 · Cited by 3
Äijö, T., Gioulbasani, M., Valenzuela, J. E., & Tsagaratou, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638500 · Cited by 3
“Instead, secondary mutations are required to result in cancer emergence (9, 14).”
Liu, B., Wang, Y., Chu, X., Wang, J., Pan, T., Xie, L., Abankwah, J. K., & Bian, Y. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156187 · Cited by 3
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation
Leesang, T. E., Brabson, J. P., Yap, Y. S., Barbieri, D. A., Klimas, A. S., Pinzone, J., Ahearn, E. L., Lam, M. Q., Lyon, P. D., Swirski, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116379 · Cited by 3
“Previous studies in murine models have shown that Tet2 and Tet3 both act as tumor suppressors of the myeloid lineage, 4,12,45 and TET2 mutation 5 or decreased expression of either TET2 or TET3 is associated with more aggressive disease in patients with AML.”
Epigenetics and disease progression in neuroendocrine neoplasms
Lobato, E. C., Lafranchi, A., Freitas-Castro, F., Fagundes, G. F. C., Sadiković, B., Lines, K. E., & Almeida, M. Q. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag005 · Cited by 3
de Munnik, M., Brasnett, A., Zhou, T.-K., Myers, W., Wang, Y.-C., Chatterjee, K., Tumber, A., Marshall, S. A., Simon, P. S., Aller, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69425-w · Cited by 4
Zhu, H., Luo, S., Liu, C., Cheng, Y., Ren, Z., Mo, J., Cao, C., Cui, J., Yan, J., Jiang, Y., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adx8909 · Cited by 3
DNMT3A in cancer: from epigenetic writer to oncogenic driver
Dupas, T., Gautreau, E., Josianne, C., Raynal, N. J. ‐., & McGraw, S. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02127-8 · Cited by 3
“The role of these proteins in cancer has been widely reviewed [68, 69].”
Wang, Z., Wang, J., Liu, F., Sun, S., Zheng, Q., Hu, X., Yin, Z., Xie, C., Wang, H., Wang, T., et al. (2024) · FEBS Letters · doi:10.1002/1873-3468.14889 · Cited by 4
“Mechanistically, TFs can recruit epigenetic enzymes and guide them to specific genomic loci, allowing them to precisely modify genomic DNA or histone tails at target genes [13,14].”
BackgroundThe physiological functions of ascorbate in the development of cancer
Agathocleous, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052201 · Cited by 4
Kgatle, M. M., Mbambara, S., Khoza, L., Fadebi, O. O., Mashamba-Thompson, T. P., & Sathekge, M. M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1602497 · Cited by 4
“Reduced TET activity can result in hypermethylation of tumor suppressor genes, contributing to cancer development (Thienpont et al., 2016; Rasmussen and Helin, 2016).”
Singh, R., Parchwani, D. N., Sharma, G., & Sharma, P. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-025-01341-0 · Cited by 3
“Conversely, TET enzymes (TET1, TET2, and TET3) belonging to the α-KGDD family work to demethylate DNA by oxidizing 5mC to 5-hydroxymethylcytosine (5hmC) with simultaneous generation of intermediates, thus reactivating genes silenced by hypermethylation [114, 115].”
Antioxidant and antihypoxic properties of neuroprotective drugs
Poloznikov, A. A., Smirnova, N. A., Khristichenko, A. Y., Hushpulian, D. M., Nikulin, S. V., Tishkov, V. I., Gaisina, I. N., & Gazaryan, I. G. (2016) · Russian Chemical Bulletin · doi:10.1007/s11172-016-1687-2 · Cited by 3
The epigenetics of multiple sclerosis
Christensen, T., & Muchardt, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813796-3.00005-5 · Cited by 3
Epigenetic Enzymes and Drawbacks of Conventional Therapeutic Regimens
Ganai, S. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8019-8_2 · Cited by 3
Qiao, Y., Zhou, Y.-H., Yang, H., He, Z., & Fan, A. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.3.4 · Cited by 4
“The frequency of Tet2 mutations in patients with MDS is 6%–26%, and CMML is 20%–58%, and it is also frequently observed in primary and secondary AML (12%–32%), blastic plasmacytoid dendritic neoplasm (25%–54%) and myeloproliferative neoplasms (MPNs), such as polycythemia vera, primary myelofibrosis, and essential thro…”
BackgroundDNA hypomethylation in wood frog liver under anoxia and dehydration stresses
Kupakuwana, P., Singh, G., & Storey, K. B. (2024) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2024.111005 · Cited by 6
Sokolova, V., Gruber, R., Pammer, L. M., Kocher, F., Klieser, E., Amann, A., Pichler, R., Günther, M., Ormanns, S., Neureiter, D., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10169-5 · Cited by 3
“The ten-eleven translocation (TET) protein family influences epigenetics, initiates demethylation pathways and is associated with tumorigenesis [133, 134].”
Li, J., Wang, C., Yang, C., Bao, H., Li, N., Huang, X., Gong, W., Hong, X., Yin, J. C., Pang, J., et al. (2025) · Cancer Science · doi:10.1111/cas.16432 · Cited by 3
“(D) Distribution of the SNVs of PIK3CA in the MSS and MSI groups. of mismatch repair genes; 18 as a DNA methylation regulator, 19 the role of TET2 in MSI CRC is worthy of further study.”
PRAME Expression in Melanoma is Negatively Regulated by TET2-Mediated DNA Hydroxymethylation
Fang, R., Vallius, T., Zhang, A., Cura, D. V., Alicandri, F., Fischer, G. M., Draper, E. C., Xu, S., Pelletier, R. J., Wang, J., et al. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104123 · Cited by 3
Espoirs et promesses de la méthylation de l’ADN et des histones comme cibles anticancéreuses
Bon, C., Erdmann, D., Halby, L., & Arimondo, P. B. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.08.001 · Cited by 3
Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
Pasquier, F., Chahine, C., Marzac, C., & de Botton, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1792286 · Cited by 3
Toubiana, S., Tzur-Gilat, A., & Selig, S. (2021) · Life · doi:10.3390/life11040278 · Cited by 3
“DNA methylation is also regulated by active demethylation carried out by enzymes from the ten-eleven translocation methylcytosine dioxygenases (TET) family of proteins, and mutations in TET genes have been implicated in hypomethylated states in various cancers [45,46].”
BackgroundEpigenetics in precision medicine of pancreatic cancer
Kim, H. S., & Shi, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00016-0 · Cited by 3
Chromatin and Epigenetics at the Forefront: Finding Clues among Peaks
Aranda, S., Shi, Y., & Croce, L. D. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00328-16 · Cited by 4
“That last oxidized form is finally transformed into an unmodified cytosine by the action of the thymidine-DNA glycosylase (Tdg) and the base excision repair system (39).”
BackgroundDNA Methylation Changes in Cancer
Thomson, J. P., & Meehan, R. R. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59786-7_4 · Cited by 3
High Doses of Vitamin C and Leukemia: In Vitro Update
Mastrangelo, D., Massai, L., Fioritoni, G., Lo‐Coco, F., Noguera, N. I., & Testa, U. (2018) · InTech eBooks · doi:10.5772/intechopen.71484 · Cited by 3
“Decreased TET expression and loss of 5hmC have been observed in a wide variety of solid tumors, as well as in many hematological malignancies, including acute myeloid leukemias, myelodysplastic syndromes, and clonal hematopoiesis [114].”
BackgroundHuang, C.-H., & Chang, C. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.05.49 · Cited by 3
“It is well-known that DNA methylation at cytosine bases in the genome is tightly linked to gene expression and modified cytosines, resulting in a G/T mismatch, and has long been recognized as a hotspot for mutations (9).”
BackgroundEpigenetics of diabetic wound healing
Singh, K., & Sen, C. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816413-6.00009-5 · Cited by 4
Overview of Epigenetic Signatures and Their Regulation by Epigenetic Modification Enzymes
Ganai, S. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8179-3_1 · Cited by 3
The influence of tissue spatial geometry and functional organisation on liver regeneration
Aloia, L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.011 · Cited by 4
“Of note, TET1 epigenetic activity inducing cholangiocyte de-differentiation, is dependent on 2-OG [97].”
Zhang, X., Yan, C., Chu, Z., Shi, L., Zheng, Y., Zhao, Q., Geng, S., & Guo, K. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106190 · Cited by 3
Mehmood, R., Alsaleh, A., Want, M. Y., Ahmad, I., Siraj, S., Ishtiaq, M., Alshehri, F. A., Naseem, M., & Yasuhara, N. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3020029 · Cited by 3
“Disruption in the activities of members of “readers”, “writers” and “erasers” of DNA methylation has been reported [25,26].”
CpG Islands and DNA Methylation
Antequera, F. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0005027.pub3 · Cited by 3
Metadata
- Authors
- Rasmussen, K. D., & Helin, K.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Helin, Kristian
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-04-01
- Volume
- 30
- Issue
- 7
- Pages
- 733-750
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC4826392
- OpenAlex
- W2325267338
- Cited by
- 1,040
- References
- 162
- Citations by year
- 2026: 56 · 2025: 87 · 2024: 116 · 2023: 100 · 2022: 135 · 2021: 141 · 2020: 131 · 2019: 97 · 2018: 83 · 2017: 60 · 2016: 30
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Genes & Development (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Danish Medical Research Council (1333-00120B)
- European Research Council (294666_DNAMET)
- Danish Cancer Society
- Danish National Research Foundation (DNRF 82)
- Danish Council for Strategic Research
- Novo Nordisk Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- TET enzymes, DNA methylation, 5-methylcytosine oxidation, TET2, demethylation, cancer, developmental regulation, transcriptional regulation, gene expression
- MeSH terms
- Animals, Cytosine, DNA-Binding Proteins, Humans, Neoplasms, Oxidation-Reduction, Proto-Oncogene Proteins, Gene Expression Regulation, Neoplastic, DNA Methylation, Epigenesis, Genetic, Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review